ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,914 | +4.7% | 12,040 | +20.3% | 0.01% | +11.1% |
| Q2 2023 | $239,668 | +35.7% | 10,007 | +6.6% | 0.01% | +28.6% |
| Q1 2023 | $176,607 | -1.4% | 9,384 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $179,141 | +17.1% | 9,384 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $153,000 | +15.9% | 9,384 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $132,000 | -41.9% | 9,384 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $227,000 | +3.7% | 9,384 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $219,000 | +40.4% | 9,384 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $156,000 | -31.9% | 9,384 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $229,000 | -44.7% | 9,384 | -4.3% | 0.01% | -65.2% |
| Q1 2020 | $414,000 | 0.0% | 9,809 | +1.4% | 0.02% | +27.8% |
| Q4 2019 | $414,000 | +28.6% | 9,675 | +8.3% | 0.02% | +20.0% |
| Q3 2019 | $322,000 | +34.7% | 8,937 | 0.0% | 0.02% | +36.4% |
| Q2 2019 | $239,000 | -4.8% | 8,937 | -4.3% | 0.01% | -8.3% |
| Q1 2019 | $251,000 | +91.6% | 9,340 | +15.0% | 0.01% | +71.4% |
| Q4 2018 | $131,000 | -22.5% | 8,124 | 0.0% | 0.01% | -12.5% |
| Q3 2018 | $169,000 | +36.3% | 8,124 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $124,000 | -43.4% | 8,124 | +32.1% | 0.01% | -60.0% |
| Q4 2015 | $219,000 | +7.9% | 6,151 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $203,000 | -21.3% | 6,151 | 0.0% | 0.02% | -11.8% |
| Q2 2015 | $258,000 | +12.2% | 6,151 | -12.9% | 0.02% | +13.3% |
| Q1 2015 | $230,000 | +2.7% | 7,060 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $224,000 | – | 7,060 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |